SNBL is SEND ready

The FDA requires data from single and repeated-dose general toxicity and carcinogenicity preclinical studies that begin after December 17, 2016 to be submitted electronically in Standard for Exchange of Nonclinical Data (SEND) format.

Read More

Exhibition at the 3rd Regenerative Medicine Expo & Conference Japan

We will present at the joint exhibition with KOBE Biomedical Innovation Cluster at the 3rd Regenerative Medicine Expo & Conference Japan held at INTEX Osaka, on February 15 [Wed] to 17 [Fri], 2017.

Read More

New GLP Measurements Offered

May 10, 2016: GLP measurement using the ultrasensitive Erenna immunoassay begins

Read More

L-Boshi Award Recipient

Shin Nippon Biomedical Laboratories, Ltd., received the highest level of the L-Boshi award and certification from the Japanese Ministry of Health, Labour, and Welfare for being a woman-friendly workplace.